The study investigates the effects of hypothalamic leptin gene therapy on bone marrow adiposity and bone health in leptin-deficient ob/ob mice fed both regular and high-fat diets. The treatment notably reduced marrow adiposity and increased both osteoblast and osteoclast perimeters, although it did not lead to a significant increase in overall bone mass compared to control groups. These findings suggest that while leptin influences the differentiation of mesenchymal stem cells toward bone-forming cells, simply reducing marrow adiposity does not guarantee an increase in bone volume, indicating a complex interaction between these processes.